NEW YORK / Apr 11, 2023 / Business Wire / Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today released its inaugural Environmental, Social, and Governance (ESG) Report for 2022. The report outlines the strategies and initiatives that Oscar has developed, and continues to iterate, to help build a more sustainable and equitable future within its organization and communities.
“Oscar's mission anchors our work in advancing health equity,” said Oscar CEO, Mark Bertolini. “As a purpose-driven organization, ESG principles are embedded into much of what we do. This report is an affirmation of our ongoing responsibility to meet the needs of our members and the communities we serve.”
Key highlights detailed in the report include:
To view Oscar’s full ESG Report, visit the ESG tab on Oscar’s Investor Relations website.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members. At Oscar, our mission is to make a healthier life accessible and affordable for all. Headquartered in New York City, Oscar has been challenging the health care system's status quo since our founding in 2012. The company’s member-first philosophy and innovative approach to care has earned us the trust of over one million members as of January 31, 2023. We offer Individual & Family, Small Group and Medicare Advantage plans, and +Oscar, our full stack technology platform. Our vision is to refactor health care to make good care cost less. Refactor is a term used in software engineering that means to improve the design, structure, and implementation of the software, while preserving its functionality. At Oscar, we take this definition a step further. We improve our members’ experience by building trust through deep engagement, personalized guidance, and rapid iteration.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements containing information about environmental, climate, diversity, equity, and inclusion, or other “ESG” targets, goals and commitments. In some cases, you can identify forward-looking statements by terms such as “continue,” “affirmation,” “ongoing,” “seek,” or “aim” or the negative of these terms or other similar expressions. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”), and our other filings with the SEC. You are cautioned not to place undue reliance on any forward-looking statements made herein. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.
1 Unlimited $0 copays for Primary Care Provider visits are not available on all plans. $0 Tier 1 Rx and Labs are available to members on select Silver and Gold plans when ordered or referred by an Oscar Care provider. Consult plan benefits for more information at https://www.hioscar.com/member/documents-and-forms. Prescriptions may be limited per provider discretion. $0 prescription refills are via Oscar’s Virtual Urgent Care offerings. $3 Prescriptions include up to 30-day supply of medication and are not available in NY, NJ, CA, or for Catastrophic plans, small group plans, or Medicare plans. Virtual Urgent Care offerings are not available in U.S. territories or internationally. If members have an HSA-compatible high-deductible health plan or a Secure plan, members won't be eligible for $0 visits. Prescriptions, visits and services may be limited per provider discretion.
Last Trade: | US$14.82 |
Daily Change: | 0.04 0.27 |
Daily Volume: | 2,337,038 |
Market Cap: | US$3.140B |
February 04, 2025 November 07, 2024 August 22, 2024 August 07, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load